Solarvest BioEnergy Inc.
TSX VENTURE : SVS

Solarvest BioEnergy Inc.

September 10, 2014 08:30 ET

Solarvest Signs Agreements With EU Production Facilities for Its Organic Omega-3 Algae Products

MONTAGUE, PRINCE EDWARD ISLAND--(Marketwired - Sept. 10, 2014) - SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest") in order to accelerate its market presence and to satisfy demand for its Organic Omega products, Solarvest has signed agreements with two EU contract production facilities. These facilities will implement Solarvest's proprietary production process and algae strains to produce high value Omega-3's to Solarvest's specifications.

Facility One: At this facility, production of high-DHA product samples has commenced that will be suitable for formulation and testing by prospective customers in the EU and North America. This production agreement will ensure the rapid procurement of sample product for Solarvest's customers to formulate and test Solarvest's all-natural organic Omega-3's in their existing products and applications. Analysis will be done to generate data for registration as a nutritional food ingredient.

Facility Two: This facility is currently producing high quality, EU approved, organic products and Solarvest is working with them to facilitate commercial scale production using Solarvest's process. The Company is scaling up to produce commercial production volumes.

Production at these facilities will coincide with the continued development of the Company's production capabilities at its PEI facility.

The Company intends to sell the bulk Omega-3 product produced at the EU facilities to food processors, while Solarvest's PEI facility will continue to develop downstream processing, finishing procedures and technologies required to produce high value added Omega products to satisfy specific customer specifications.

About Solarvest BioEnergy Inc.:

Solarvest BioEnergy Inc. is an algae technology company that owns numerous key patents and whose algal-based production platform provides it with an extremely flexible production system. The company's wholly owned subsidiary Solarvest PEI has developed a patented (pending) process to produce the world's first organic Omega-3 using algae, to help meet the 13 billion dollar global Omega-3 market. The Solarvest system utilizes a natural process growing the algae under closely controlled conditions ensuring that the health product(s) produced have none of the environmental contaminants found in our oceans. Organic certification provides assurance that the product(s) is GMO free, sustainable, produced without chemicals and, being algae, supports vegetarian and vegan diets. Solarvest's licensed Organic Omega-3 products will offer the consumer a healthy and sustainable product choice.

The TSX Venture Exchange has neither approved nor disapproved the contents of this news release.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The statements made in this news release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from Solarvest's expectations and projections.

Contact Information